English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 天
Greenwich LifeSciences公布GLSI-100安全性数据显示积极结果
Greenwich LifeSciences首席执行官Snehal Patel对初步安全性数据以及使用注射部位反应直径评估免疫反应程度的潜力表示满意。公司预计将进一步分析免疫反应数据并与IIb期结果进行比较。分析师保持乐观展望,共识目标价为38美元,显示出相对当前水平的显著上涨潜力。投资者可通过 InvestingPro 获取更深入的GLSI财务健康状况和增长前景分析。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Agrees to limited ceasefire
On judicial impeachment call
DC drops Jan. 6 lawsuit
Halts care for trans veterans
Removing privacy setting
US retail sales rebound
US housing starts rebound
'Get Together' singer dies
Fire danger continues for OK
Producer files for bankruptcy
Peru declares emergency
Earthquake shakes Bay Area
JFK files to be released
Trump revokes protection
Bryan Bedford to lead FAA
Reinstating fired workers
Lebanon-Syria ceasefire
Judge demands answers
Visits White House
DOGE gains access to USIP?
Tapped as top bank cop
Honduras plane crash
Ordered to pay $54K+
Lunar lander goes silent
Parents on missing daughter
Worker stole $1.6 million
Texas midwife arrested
Delta plane wing hits runway
Acquires AI video startup
Ex-Texas pastor surrenders
ISR conducts strikes in Gaza
反馈